42
Views
21
CrossRef citations to date
0
Altmetric
Anticancer Chemotherapy

FOLFOX-4 Regimen as First-Line Chemotherapy in Elderly Patients with Advanced Gastric Cancer: A Safety Study

Pages 85-89 | Published online: 18 Jul 2013

References

  • Ho D: Epidemiologic studies in gastric cancer, in Ho D (ed). Gastric Cancer. New York, NY, Churchill Livingstone, 1988: 1-25.
  • Kohne CH, Wils JA, Wilke HJ. Developments in the treatment of gastric cancer in Europe. Oncology (Huntingt) 2000; 14: 22–25.
  • Webb A, Cunningham D, Scarffe JH, et al. Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus flu-orouracil, doxorubicin, and methotrexate in advanced esopha-gogastric cancer. J Clin Oncol 1997; 15: 261–267.
  • Ajani JA, Van Cutsem E, Moiseyenko V, et al. Docetaxel (D), cisplatin, 5-fluorouracil compare to cisplatin (C) and 5-fluorouracil (F) for chemotherapy-naive patients with metastatic or locally recurrent, unresectable gastric carcinoma (MGC): Interim results of a randomized phase III trial (V325). Proc Am Soc Clin Oncol 2005; 23: abstr 4002.
  • Louvet C, Andre T, Tigaud JM et al. Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients. J Clin Oncol 2002; 20: 4543–4548.
  • Al-Batran SE, Amaca A, Hegewisch-Becke S et al: Phase II Trial of Biweekly Infusional Fluorouracil, Folinic Acid, and Oxaliplatin in Patients With Advanced Gastric Cancer. J Clin Oncol 2004; 22: 658–663.
  • Chao Y, Yeh KH, Chang CJ et al. Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluo-rouracil and folinic acid in the treatment of advanced gastric cancer. Br J Cancer 2004; 91: 453–458.
  • De Vita F, Orditura M, Matano E et al. A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients. Br J Cancer 2005; 92: 1644–1649.
  • Lordick F, Lorenzen S, Stollfuss J et al. Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer. Br J Cancer 2005; 93: 190–194.
  • Therasse P. Measuring the clinical response. What does it mean? Eur J Cancer 2002; 38,18: 17–23.
  • Davies I. Theories and general principles of aging. In: Textbook of geriatric medicine and gerontology (4th edn.), Brckle-Bust JC, Tallis RC, Fillit HM (Hs), Churcill Livingstone, Edinburgh, 1992: 26-608.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.